NeuroMolecular Medicine

Show Articles
Journal Properties
  • Number of Articles
    162
  • Abbreviation
    NeuroMol Med
  • e-ISSN
    1535-1084
  • Publisher
    Springer Science and Business Media LLC
  • Indian UGC
  • DOAJ (latest)
Description
Neuromolecular Medicine advances understanding of diseases at the molecular level. It explores the intricate relationship between neurological disorders and their molecular underpinnings, offering insights into disease mechanisms and potential therapeutic targets. The journal delves into topics such as neurodegenerative diseases, psychiatric disorders, and the impact of genetic and epigenetic factors. Key areas covered include molecular signaling pathways, gene expression patterns, proteomics, and metabolomics in the context of neurological and psychiatric conditions. Indexed in databases such as PubMed/MEDLINE, Scopus, and Web of Science, it reaches researchers, clinicians, and pharmaceutical scientists interested in innovative approaches to neurological and psychiatric medicine. Neuromolecular Medicine strives to bridge the gap between basic science discoveries and clinical applications. It highlights novel therapeutic strategies and diagnostic tools, fostering collaboration between basic researchers and clinical practitioners. By providing a platform for cutting-edge research, it aims to catalyze advancements in the treatment and prevention of neurological and psychiatric illnesses. With its focus on molecular mechanisms, the journal contributes to the development of more targeted and effective interventions, improving patient outcomes.